Head-to-head · Cost-Efficiency Index
Mojoon vs Nuform Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Mojoon
Shoppers comfortable reading past a marketing headline to a lower published starting-dose price.
Visit MojoonNuform Health
Shoppers willing to prepay a multi-month term upfront to hit the lowest advertised per-month rate.
Visit Nuform HealthThe verdict
Mojoon and Nuform Health tie on the Cost-Efficiency Index at 53/100, so neither wins outright on the numbers. For most shoppers we'd start with Mojoon (ranked #377, a hair above #378) — Shoppers comfortable reading past a marketing headline to a lower published starting-dose price. But Nuform Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Mojoon.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Mojoon | Nuform Health |
|---|---|---|
| Cost-Efficiency Index | 53/100 | 53/100 |
| Semaglutide / mo | $350/mo (0.25 mg dose, compounded) | $129/mo (starting dose, compounded) |
| Tirzepatide / mo | Not disclosed | $199/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $4,200 | $1,548 |
| Tirzepatide / yr (modeled) | — | $2,388 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #377 | #378 |
Mojoon
53/100Where the value is
- Publishes an actual price range ($350-$520/treatment) rather than a single vague 'starting at' figure, and explains why the price rises (monthly dose escalation from 0.25 mg to 2.4 mg)
- Claims LegitScript certification, and pharmacy licensure across all 50 states for dispensing even though provider coverage is 48 states
- No long-term contract or hidden fees claimed on the product page
The tradeoffs
- The site's own prominent marketing figure ('$450 per month') is HIGHER than its own disclosed starting-dose floor ($350) — the headline number is not the entry price
- Tirzepatide is listed as an offered treatment in the navigation but its dedicated page carries no pricing at all
Nuform Health
53/100Where the value is
- Transparent about the prepay structure on the pricing page itself — the plan lengths and total dollar amounts are spelled out, not hidden behind an intake quiz
- Physician-owned and operated per its own claim, with named co-founders
- Maintenance-tier pricing (for ongoing refills after the starter course) is published alongside starter pricing, not just the entry offer
The tradeoffs
- The advertised '$129/mo' and '$199/mo' figures are NOT month-to-month prices — the site explicitly does not offer monthly billing, and the real charge is a $389 or $499 lump sum due upfront for a 2.5-3 month term
- A separate '$170 physician fee' is advertised on the homepage but not reconciled anywhere against the GLP-1 pricing breakdown, so whether it stacks on top of the prepay plans is unconfirmed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.